Search / Trial NCT06230406

T-Mem GEne in Atherosclerosis

Launched by IRCCS POLICLINICO S. DONATO · Jan 19, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "T-Mem Gene in Atherosclerosis" is exploring how a specific gene, called TMEM230, may be involved in the development of atherosclerosis, a condition where arteries become clogged with fatty substances. This condition is a major cause of heart disease and can lead to serious health issues. Researchers want to understand how this gene works in the body and whether targeting it could help prevent or treat atherosclerosis, potentially reducing the risk of heart-related problems.

To participate in this study, you need to be an adult over 18 years old and willing to give your consent. You should also be visiting the Vascular Surgery Unit at IRCCS Policlinico San Donato for a vascular issue that requires surgical treatment. Unfortunately, if you are under 18 or have a vascular condition that cannot be treated with surgery, you won't be eligible for this trial. If you decide to take part, you will help researchers learn more about the role of this gene in atherosclerosis, which could lead to new ways to manage heart disease in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients (age \> 18 years)
  • consent to participate in the study,
  • patients coming to the Vascular Surgery Unit I of the IRCCS Policlinico San Donato for a vascular pathology of the arterial or venous district worthy of surgical treatment.
  • Exclusion Criteria:
  • minor patients,
  • patients who have not given their consent to participate in the study,
  • patients who have vascular pathologies of the arterial or venous district not susceptible to surgical intervention.

About Irccs Policlinico S. Donato

IRCCS Policlinico S. Donato is a leading Italian research hospital and clinical trial sponsor dedicated to advancing medical science through innovative research and patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it is recognized for its commitment to high-quality clinical research and the integration of scientific investigation with clinical practice. The institution specializes in various medical fields, including cardiology, oncology, and neurology, and collaborates with universities and research organizations to facilitate cutting-edge studies. With a focus on improving patient outcomes and contributing to public health, IRCCS Policlinico S. Donato plays a pivotal role in the development of new therapies and treatment protocols.

Locations

San Donato Milanese, Milan, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0